Samalin Investment Counsel’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
AACR
HGIM
FI
DC
CF
MIHAS
Samalin Investment Counsel's ELV Position: Q2 2026 in Review
Samalin Investment Counsel increased its Elevance Health (ELV) stake by 0.14% in Q2 2026, buying an estimated $371 and bringing the position to 705 shares worth $273K. The position accounts for 0.09% of the portfolio, ranked #262.
Samalin Investment Counsel first reported a position in ELV in Q4 2019 and has held it in 21 quarters since. The position peaked at $512K in Q4 2023. 565 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Samalin Investment Counsel held 705 shares of Elevance Health worth $273K as of Q2 2026.
- Samalin Investment Counsel bought 1 Elevance Health share in Q2 2026, an estimated $371.
- Elevance Health made up 0.09% of Samalin Investment Counsel's portfolio in Q2 2026, its #262 holding.
- Samalin Investment Counsel first reported a position in Elevance Health in Q4 2019 and has held it in 21 quarters since.
- Samalin Investment Counsel's Elevance Health position peaked at $512K in Q4 2023.
- 565 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Samalin Investment Counsel's 13F filing for Q2 2026, filed 27 Jul 2026.